glp-1 drugs food industry impact news today The of on the Lighter Carts and Shrinking Profits:

Cell Death Dis 16(1):259 Results from Phase 2 COURAGE Trial Demonstrating Potential to Improve Quality of GLP-1 receptor agonist-induced Weight Loss by Preserving Lean Mass, Presented at 61st EASD Annual Meeting 2025, Wien [press release] Dalton JT, Barnette KG, Bohl CE, Hancock ML, Rodriguez D, Dodson ST et al (2011) The selective androgen receptor modulator GTx-024 (enobosarm) improves lean body mass and physical function in healthy elderly men and postmenopausal women: results of a double-blind, placebo-controlled phase II trial

Consequently, a 30-pound weight loss could reduce knee loading by 90-120 pounds with each step, representing substantial mechanical relief

The study showed people taking GLP-1 drugs also had lower risks of some kinds of infections including pneumonia, sepsis and bacterial infections

10.1038/npp.2011.220 [DOI] [PMC free article] [PubMed] [Google Scholar] Haroon E., Miller A

After puncturing the skin with a needle tip on the large toe of the hind limb, a drop of blood was applied to the test strip

Urva S, Coskun T, Loh MT, et al